LFG
WVE icon

Larson Financial Group’s Wave Life Sciences WVE Stock Holding History

Larson Financial Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.6K Sell
1,308
-775
-37% -$5.14K ﹤0.01% 2562
2026
Q1 		$15.1K Buy
2,083
+1,241
+147% +$16.2K ﹤0.01% 2003
2025
Q4 		$14.3K Buy
842
+150
+22% +$1.52K ﹤0.01% 1916
2025
Q3 		$5.07K Sell
692
-736
-52% -$5.96K ﹤0.01% 2349
2025
Q2 		$9.28K Buy
1,428
+586
+70% +$3.87K ﹤0.01% 1845
2025
Q1 		$6.8K Buy
+842
New +$9.21K ﹤0.01% 1782

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Larson Financial Group's WVE Position: Q2 2026 in Review

Larson Financial Group reduced its Wave Life Sciences (WVE) stake by 37% in Q2 2026, selling an estimated $5.14K and leaving 1,308 shares worth $7.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Larson Financial Group first reported a position in WVE in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.1K in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Larson Financial Group held 1,308 shares of Wave Life Sciences worth $7.6K as of Q2 2026.
  • Larson Financial Group sold 775 Wave Life Sciences shares in Q2 2026, an estimated $5.14K.
  • Wave Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2562 holding.
  • Larson Financial Group first reported a position in Wave Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Wave Life Sciences position peaked at $15.1K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.